scholarly journals Attitudes and Perceptions Towards Coronavirus Disease 2019 (COVID-19) Vaccine Acceptance Among Recovered African American Patients

Author(s):  
Titilope Olanipekun ◽  
Temidayo Abe ◽  
Valery Effoe ◽  
Suaka Kagbo-Kue ◽  
Iloabueke Chineke ◽  
...  
Author(s):  
Krutika Kuppalli ◽  
David M Brett-Major ◽  
Tara C Smith

Abstract In this perspective, we discuss the importance of developing a vaccine to help curb transmission of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The question remains: once a safe and effective vaccine is developed, will the public be willing to get it? We present information from one of the first tracking polls to assess public attitudes and perceptions towards a possible Coronavirus Disease 2019 (COVID-19) vaccine that suggests public hesitancy over a potential vaccine, concern regarding accelerating clinical trials, and unease over the vaccine approval process. Public health experts, government officials, advocates, and others in the scientific community should respect the signals of hesitancy and communicate sensitivity, applying lessons not only to how we message, but also in how we build this urgently needed vaccine if we are to have successful uptake once available.


Vaccine ◽  
2017 ◽  
Vol 35 (5) ◽  
pp. 802-807 ◽  
Author(s):  
Linda Y. Fu ◽  
Gregory D. Zimet ◽  
Carl A. Latkin ◽  
Jill G. Joseph

2017 ◽  
Vol 24 (3) ◽  
pp. 323-340 ◽  
Author(s):  
Kayoll V. Galbraith-Gyan ◽  
Julia Lechuga ◽  
Coretta M. Jenerette ◽  
Mary H. Palmer ◽  
Angelo D. Moore ◽  
...  

Vaccines ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1071
Author(s):  
Kimberly R. Nehal ◽  
Lieke M. Steendam ◽  
Maiza Campos Ponce ◽  
Marinka van der Hoeven ◽  
G. Suzanne A. Smit

Countries across the globe are currently experiencing a third or fourth wave of SARS-CoV-2 infections; therefore, the need for effective vaccination campaigns is higher than ever. However, effectiveness of these campaigns in disease reduction is highly dependent on vaccination uptake and coverage in susceptible populations. Therefore, this systematic review and meta-analysis estimated the vaccination intention and identified determinants of willingness and hesitancy. This study updates the existing body of literature on vaccination willingness, and was conducted according to the PRISMA guidelines. PubMed was searched for publications, selecting only studies published between 20 October 2020 and 1 March 2021, in English, with participants aged >16 years of age. The search identified 411 articles, of which 63 surveys were included that accounted for more than 30 countries worldwide. The global COVID-19 vaccination willingness was estimated at 66.01% [95% CI: 60.76–70.89% I2 = 99.4% [99.3%; 99.4%]; τ2 = 0.83]. The vaccination willingness varied within as well as between countries. Age, gender, education, attitudes and perceptions about vaccines were most frequently observed to be significantly associated with vaccine acceptance or refusal.


Sign in / Sign up

Export Citation Format

Share Document